From The Perspective Of The Major Tobacco Companies, The Current Regulatory Trends Of E-cigarettes in The United States

On October 28th, British American Tobacco (BAT) suddenly announced that it would suspend the pilot program for launching the single-use e-cigarette product Vuse One in the US market.
This decision, seemingly just a product adjustment at the enterprise level, has triggered a chain reaction throughout the industry - because it means that even the big tobacco giants can no longer "evade regulation" and act without oversight.
01 Giants' Trial|From "Gray Shelfing" to "Active Contraction" In the past few years, the regulation of e-cigarettes in the United States has been in a gray area. Due to the lengthy and costly PMTA approval process of the FDA (Food and Drug Administration), many brands chose the strategy of "launching first and then applying for approval".
Even some traditional tobacco giants attempted to seize the market during this period of ambiguous regulation.
BAT's Vuse One is a product of this "gray trial". As an extension of the Vuse brand, it targets the fastest-growing and most profitable sub-market of disposable e-cigarettes. However, with the recent increased enforcement by the FDA and the comprehensive inspection of "unauthorized" products, BAT ultimately chose to pause.
The spokesperson explained that the company would "focus on its existing product line", but the industry generally believes - this is a forced strategic contraction.
This is not an isolated case.
Philip Morris International (PMI) originally planned to "test the waters" with a variant product of Zyn nicotine pouches for unlicensed listing, but ultimately chose to abandon it, citing "waiting for a simplified approval system".
Oriental Tobacco (Altria) is still advancing its market plan for its new nicotine pouch On!, although it has not yet been approved, it has also significantly slowed down its pace.

When even the big tobacco companies dare not cross the line, the "gray era" of the US e-cigarette market is approaching its end.
02 Accelerated Regulation|FDA's "Iron Fist and Reform" Running Parallel FDA's attitude is undergoing a fundamental change.
On the one hand, it is conducting a large-scale cleanup of unlicensed products - especially disposable e-cigarettes from China with fruit or sweet flavors;
On the other hand, it is also attempting to launch a simplified approval pilot project to alleviate the long-standing backlog of PMTA.
This means that the US market is entering a "dual-track stage":

The other side is reforming the system and accelerating the approval process. This combination makes the industry both tense and expectant.

Expectant is that there might really be a more efficient compliance path in the future.
But the FDA is also striving to draw a line - "Simplifying the process does not mean relaxing the standards".
The regulatory authorities clearly stated: All nicotine vaping products must obtain PMTA authorization, scientific data and safety assessment remain the core standards.
03 Behind the Game|The Struggle of Big Tobacco and Silent Competition The scale of the US e-cigarette market is approximately $22 billion, but the profits of the giants are being rapidly eroded by "unlicensed products".
Most of these products come from the Chinese supply chain, are priced low, are launched quickly, and have a youthful packaging, which has a significant market impact. This has put traditional tobacco companies in an unprecedented dilemma: Compliance and law-abiding means losing the market opportunity; Illegal trial means facing a heavy regulatory blow. BAT's pause, PMI's wait-and-see, and Altria's cautious advancement actually reflect this global anxiety.
The giants are all waiting - waiting for the reform of the FDA to bring a clearer and more operational market channel.
But during this waiting period, the most difficult reality for big tobacco is that regulation is tightening, but consumer demand has not disappeared.
04 Insights and Recommendations for Chinese E-cigarette Companies For Chinese enterprises, the changes in the US market are not only a challenge, but also a cognitive upgrade.

The current logic is "run steadily, survive longer". The gray export model is about to end. FDA is tracing the source from the retail terminal upwards, any product without PMTA authorization may be included in the risk list.
The old model of "brand licensing + large-scale production" will become increasingly risky, and both the brand owners and the factories may be affected. The compliance ability of B will become a new barrier. The future competition will no longer be about production capacity, but rather who can "pass the PMTA faster" in the United States.
Chinese enterprises can consider jointly establishing an application alliance for PMTA, building an experimental data center together, or entrusting overseas institutions to apply on their behalf to reduce costs and shorten the cycle. C Brand power and trust will become the decisive factor. In a highly regulated environment, American consumers will be more inclined to purchase products with "visible identities".
This means that Chinese brands can no longer merely do OEM work, but should establish a compliant image in terms of packaging, ingredients, and transparency.
"Made in China" needs to be upgraded to "Certified in USA". D Market focus is diversified outside the United States. The EU, the Middle East, Latin America, and other markets still have policy windows.
It is necessary to make early preparations for a multi-market matrix to diversify the single regulatory risk. 05 Conclusion|From speed competition to rule competition From the suspension of BAT to the acceleration of FDA, the US e-cigarette market is undergoing a deep structural reshaping.

In the coming years, it will be determined by "compliance, brand, and technology" who can survive.
When major tobacco giants are forced to slow down, this is not bad news.
On the contrary, it means that the market is being reset and reorganized.
For truly technically advanced, brand-oriented, and long-term-planning Chinese enterprises -
This is an opportunity to move from "manufacturing advantages" to "rule advantages".
If you are following the next stage of e-cigarette export, please pay attention to this sentence:
"The gray window is closing, but the compliance channel is opening.
The real opportunity has always been hidden within the rules."